🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Prospective, open label, non-randomized, phase I/IIb study of F16IL2 in com...
Status
Unknown
Location
Basel University Hospital
Start Date
2017-03-09
Trial ID
NCT05468294
Treatments Being Tested
There is no standard treatment for Merkel cell carcinoma(MCC), as no random...
Status
Terminated
Location
Medical University Hospital
Start Date
2013-10-25
Trial ID
NCT02054884
Treatments Being Tested
This Phase Ib/II study is an open label, multicenter study. The study is d...
Status
Completed
Location
A.O. UNIVERSITARIA OSPEDALI RIUNITI - OSPEDALE UMBERTO I DI ANCONA - ANCONA (AN) (Italy)
Start Date
2008-08-06
Trial ID
NCT01134250
Treatments Being Tested
This Phase Ib/II study is an openlabel, multicenter study for patients with...
Status
Terminated
Location
A.O. UNIVERSITARIA OSPEDALI RIUNITI - OSPEDALE UMBERTO I DI ANCONA - ANCONA (AN) (Italy)
Start Date
2008-06
Trial ID
NCT01131364
Treatments Being Tested
Phase I, open label, non-randomized, multicenter, prospective dose escalati...
Status
Terminated
Location
Münster University Hospital
Start Date
2016-04-13
Trial ID
NCT02957032
Treatments Being Tested
Phase I, open label, single arm, non-randomized, multicenter, prospective d...
Status
Completed
Location
University Medical Center Freiburg
Start Date
2016-12-02
Trial ID
NCT03207191